| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |